Average Deal Size Benchmark: By Industry, Stage, and Rep Type

What is average deal size — and why the single number misleads most teams

Average deal size is the mean or median Annual Contract Value (ACV) across all closed-won opportunities in a period. The formula is simple: add up the total contract value of all closed deals, then divide by the number of deals. The result tells you what a typical deal looks like in dollar terms — before you adjust for outliers, before you segment by motion, and before you account for expansion revenue on top of the initial contract.

The reason the single blended average misleads: the median B2B SaaS ACV is $26,265 (SaaS Capital, 2025), but that number aggregates bootstrapped companies at $23K median and equity-backed companies at $35K median. It blends companies at $3M ARR (median ACV $29K) with companies at $10M–$20M ARR (median ACV $56K). The median for your company is only meaningful compared to companies at the same ARR stage, targeting the same buyer segment, using the same sales motion.

There is also a critical distinction between mean and median. An enterprise deal at $300K inflates the mean in a portfolio of 20 SMB deals at $15K each. The median — the midpoint deal — is far more representative of your typical close. When benchmark reports cite "average deal size," always ask whether they mean mean or median. Most authoritative sources (SaaS Capital, Optifai) report medians. Most rep-facing leaderboards report means, which rewards outliers.

Finally, average deal size is a lagging indicator. The deal that closes today was sourced 30–180 days ago. The ACV of next quarter's pipeline is determined by the ICP precision of today's outreach. Reps who treat average deal size as a report-card metric miss the point. The operational value of the metric is in identifying which rep, which lead source, which vertical, and which buyer segment is producing the highest ACV — and then systematically increasing the proportion of activity targeting those high-ACV sources. For more context on the sales metrics that belong on every leader's dashboard, see key sales metrics every CRO dashboard should track.

Average deal size benchmark by industry: SaaS, fintech, healthcare, and professional services

Industry vertical is the strongest single predictor of ACV outside of company stage. A $35K deal is above average for horizontal SaaS and below average for DevOps infrastructure. The benchmarks below come from Optifai's analysis of 939 B2B SaaS companies (Q2 2025–Q1 2026), supplemented with SaaS Capital's 2025 private company survey and SifthHub data on healthcare and MedTech deals.

Horizontal SaaS ($12K median): The most competitive and most commoditized category. Horizontal tools — productivity, project management, general CRM — face more substitutes and more price compression than vertical tools. The SMB buyer is price-sensitive and often self-serves. Enterprise deals exist but require deep customization or integration work to justify premium pricing. Teams selling horizontal tools at sub-$10K ACV typically operate in high-velocity inside sales motions with 40–80 deals per year per rep.

Sales and Marketing Tech ($28K median): The category includes CRMs, sales engagement platforms, intent data providers, and revenue intelligence tools. The SMB buyer often starts on a per-seat monthly plan that converts to an annual contract after a proof-of-value period. Enterprise deals in this category scale significantly when they involve company-wide deployment, data integrations, or custom analytics layers. This is a category with high expansion revenue potential — initial deal size frequently grows 2–3× by year two as adoption spreads.

DevOps and Infrastructure ($85K median): Technical buyers with larger budgets, longer evaluation processes, and higher switching costs. Initial deals involve rigorous security review, integration testing, and often a paid proof-of-concept period. The enterprise ceiling is high — deals at $300K–$500K+ are not uncommon for core infrastructure contracts. Reps selling in this category typically own fewer accounts, run longer cycles (90–180 days), and benefit significantly from engineering champion relationships.

Healthcare and MedTech ($60K median): HIPAA compliance requirements, clinical validation demands, and hospital procurement processes all push deal sizes up. A health system deployment with 500 clinical users justifies pricing that a 50-seat SaaS tool never sees. The compliance overhead also creates natural barriers to switching, which supports both deal size and retention. Initial deals at the SMB level (single clinic, small practice group) close in the $20K–$50K range. Health system and payer deals regularly clear $150K.

Enterprise Security ($180K median): The highest-ACV vertical in the Optifai dataset. Security budgets are driven by regulatory requirements, breach risk, and board-level visibility — not by feature comparison. Security buyers rarely negotiate on price alone; they negotiate on scope, terms, and implementation support. An initial deployment deal of $150K often leads to expansion across business units that triples TCV within 24 months. Security reps carry the fewest accounts, run the most complex multi-stakeholder deals, and require the deepest pre-call preparation on account risk profile and competitive positioning.

Average deal size benchmark by company stage: Seed through Series C+

Company stage — both the selling company's and the buying company's — is the second most predictive variable for deal size. As a company grows its ARR, its ACV should grow with it. If your ACV is flat while ARR grows, you are selling to more customers at the same price point, which typically signals either ICP expansion without pricing adjustment or a failure to move upmarket intentionally.

The ACV progression from Seed to Series C+ is not random. It reflects four compounding advantages that scale with ARR: stronger reference customers who validate the value proposition at higher price points, a more mature product that handles enterprise requirements like SSO, admin controls, and audit logging, a sales team with specialized roles (SDRs, AEs, SEs) that can run more complex deal processes, and more pricing confidence derived from retained customers proving willingness to pay.

The SaaS Capital data shows a significant ACV jump at the $10M–$20M ARR band: median ACV more than doubled year-over-year to $56K in that cohort (SaaS Capital, 2025). This is the stage where most companies make their first deliberate upmarket move — adding enterprise features, building out an enterprise AE team, and targeting larger buyers who previously rejected the product on gaps. The companies that clear this threshold fastest are those that align ICP targeting, product scope, and pricing simultaneously rather than sequentially.

Equity-backed companies show significantly higher ACV ($35K median) than bootstrapped peers ($23K median) at comparable ARR stages (SaaS Capital, 2025). The mechanism is not the capital itself — it is that equity-backed teams invest in enterprise sales infrastructure earlier: dedicated AEs, pre-sales engineers, customer success, and the feature velocity needed to compete for larger contracts. Bootstrapped companies prioritize unit economics over ACV growth. Both are valid strategies, but they produce different benchmarks, and comparing across funding types misleads.

Average deal size by rep type: SDR-sourced, AE self-sourced, inbound, and referral

Not all pipeline is created equal. Where a deal comes from — and who initiated the conversation — predicts deal size as reliably as it predicts win rate. The table below maps average deal size multiples against the inbound baseline, with win rate and source notes. The "1.0×" for inbound is the baseline; every other source is measured relative to it.

The outbound-inbound gap (50% larger deal sizes from outbound) exists for a structural reason: inbound self-selects smaller buyers. An AE who posts content, responds to demo requests, and closes whatever comes in will close a lot of deals — but the buyer who self-identifies need is often a smaller organization with a lower-complexity problem and a tighter budget. Outbound reps choose who they contact. When a rep targets a specific company because the ICP signals a buying moment — a new VP hire, a funding round, a job posting for a role the product addresses — the deal that results is larger because the account is larger and more complex.

SDR-sourced deals average smaller than AE self-sourced deals for a related reason: SDRs target volume metrics — meetings booked — not meetings booked with the largest buyer in the ICP. An SDR who hits quota on 10 meetings per month may book 3 meetings with $200K ARR companies and 7 meetings with $20M ARR companies — because the smaller companies are easier to connect with. The $200K ARR meeting is harder to book but produces a $50K+ deal. The $20M ARR meeting was easy but closes at $12K. AE self-sourced deals are larger because experienced AEs self-select accounts they know they can close at target ACV. That judgment — knowing which account to pursue at the moment a signal fires — is a core ACV driver, and it is the reason that senior AEs consistently close at higher average deal sizes than junior AEs running the same territory.

What drives deal size up or down — the six controllable factors

Average deal size is not a fixed outcome. It responds to six specific inputs — three that push ACV up and three that pull it down. Understanding the mechanism behind each one gives reps and leaders a concrete lever to pull rather than a metric to observe.

The discount factor deserves specific attention because it is the most common and least discussed ACV destroyer in B2B sales. Reps who open contract negotiations by offering a 15% discount because "the deal has been sitting in legal for three weeks" train their buyers to expect discounts on every future renewal. Excessive discounting reduces customer lifetime value by up to 30% (SalesSo, 2025), and the rep who closes at 25% below list price generates the same nominal revenue as a rep who closes three fewer deals at list price — but at significantly higher customer acquisition cost per LTV dollar. The goal of average deal size management is not just to close larger deals. It is to close deals at full pricing discipline while adding more scope where the value genuinely justifies it.

How to increase average deal size: five tactics with the underlying mechanics

Increasing average deal size is not a negotiation tactic. It is an upstream targeting, preparation, and scoping discipline. The five tactics below are not about extracting more money from the same buyer. They are about engaging the right buyer, at the right moment, with the right scope — so that the deal that results is naturally larger. Each tactic has a specific mechanism that reps can implement without changing the product or the pricing.

When to walk away from a small deal — the ROI math every AE needs

Not every deal is worth closing. A $5K deal that takes 60 days to close, requires three security reviews, involves six stakeholders, and results in a customer who churns in year one is a negative-LTV deal. The rep who closed it hit their deal-count metric and missed their ACV target. The company spent $8K–$15K in CAC to acquire a customer worth $4K at renewal. The walk-away decision is one of the highest-value moves an AE can make — and most reps never make it because their compensation plan rewards deal count over deal quality.

The walk-away does not mean losing the deal. It means qualifying out early enough that neither side wastes time. A rep who identifies a sub-ICP deal at Stage 1 and routes it to a self-serve trial or a lower-tier product offering serves the buyer correctly and preserves their own time. The rep who qualifies in every deal, regardless of deal size, and then complains about low average ACV is solving the symptom rather than the cause. The cause is an absence of ACV-based qualification criteria. Setting a minimum ACV threshold for Stage 2 investment — not as a rule to break, but as a default that requires manager approval to override — is one of the most reliable operational changes a sales leader can make to raise team average deal size within a quarter. For a broader view on how deal qualification affects win rate and ACV simultaneously, that diagnostic covers the seven root causes.

The Deal Calibration Framework: Gangly's model for targeting, preparing, and closing higher-ACV opportunities

Most ACV-improvement advice targets pricing, negotiation, or discount policy. Those levers operate at the end of the deal. The Deal Calibration Framework operates at the beginning — at the moment a rep decides which account to contact, which signal to act on, and how prepared to arrive at the first conversation. Pre-call preparation is the highest-impact ACV input that most analysis ignores.

Gangly executes all four steps automatically before every outreach touchpoint and discovery call. The pre-call brief surfaces the account size screen (does this account match target ACV parameters), the signal quality score (what triggered this outreach and how strong is that signal), a stakeholder map built from CRM data and LinkedIn enrichment, and the full account history including prior deal attempts, previous scope discussions, and last-logged activity.

The result: reps arrive at every deal already calibrated to the right scope. A rep who knows the account has grown from 50 to 150 employees since the last conversation does not propose a 10-seat deal. A rep who sees from CRM history that a prior deal stalled at $20K because security was never addressed brings a completed security questionnaire and proposes $35K with implementation support included. These are not negotiation tactics. They are preparation outcomes that naturally produce larger proposals because the rep understands the account deeply enough to scope correctly from the first conversation.

Gangly's analysis of rep performance across different preparation depths shows that reps who arrive at discovery calls with full account context — stakeholder map, signal history, CRM notes, and company growth data — propose initial deals that are 28–35% larger than reps who arrive without preparation. The difference is not negotiation skill. It is scope awareness. A rep who knows the account is deploying a new sales team knows to propose the sales team's workflow, not just the current champion's workflow. That single piece of context doubles the deal. The AI sales workflow that connects signal to close is built specifically to deliver this context at scale, across every rep, before every call.

How to measure and track average deal size in your CRM

Most CRM platforms calculate average deal size by default, but the default report hides more than it reveals. The blended average across all segments, all lead sources, and all rep types is a number that tells leadership what closed last quarter and nothing else. The actionable version of this metric requires four segmentation cuts that most teams skip.

The most actionable report is an ACV source attribution table: every closed deal in the trailing 90 days, tagged by source (inbound, SDR, AE, partner, signal), with the corresponding ACV. Sort by ACV descending. Look at the top quartile — where did those deals come from? In most teams, 70–80% of the top-quartile deals came from two or three sources. Those sources deserve a disproportionate share of outreach investment. The bottom quartile deals — the smallest ACVs — typically came from high-volume inbound or unfocused SDR sequences. These are the deals worth qualifying more aggressively, routing to self-serve, or filtering out of the pipeline before Stage 2.

For teams building out full revenue performance reporting, average deal size by source is one of five foundational metrics that belong on every CRO dashboard — alongside pipeline coverage ratio, win rate by segment, sales cycle length, and rep efficiency. The relationship between average deal size and cycle length is particularly important: larger deals take longer to close, which means ACV growth directly affects the pipeline coverage ratio required to hit quarterly targets. A team that increases ACV from $20K to $40K without lengthening the cycle needs 50% fewer deals to hit the same revenue — but almost certainly lengthens the cycle in the process. See sales cycle length benchmarks by industry and deal size for the cycle data that pairs with these ACV benchmarks.